① SMIC's annual revenue exceeds 9 billion USD, how fast is the growth rate? ② Sunac Development's January sales revenue declined by about 30%, what is the scale?
Cailian Press, February 10 (Editor: Feng Yi) Cailian Press brings you today's important Hong Kong stock announcements.
1) Corporate News
SMIC (00981.HK): Revenue for 2025 was 9.327 billion USD, an increase of 16.2% year-over-year; net profit was 685 million USD, an increase of 39.1% year-over-year, mainly due to increased wafer shipments, higher capacity utilization, and changes in product mix during the year.
The announcement stated that SMIC’s average capacity utilization rate for 2025 was 93.5%, up 8 percentage points year-over-year. In Q4 2025, the capacity utilization rate was 95.7%, revenue was 2.489 billion USD, an increase of 12.8% year-over-year, and profit was 173 million USD, a year-over-year increase of 60.7%.
In addition, revenue growth for 2026 is expected to be higher than the industry average. Capital expenditure will remain roughly flat compared to 2025. The guidance for Q1 indicates revenue will remain stable quarter-over-quarter, with gross margin between 18%-20%.
PCCW Limited (00008.HK): Revenue for 2025 increased by 7% to 40.252 billion HKD, EBITDA increased by 3% to 13.29 billion HKD, and losses narrowed further by 16% to 253 million HKD.
The announcement stated that Viu, building on its regional leadership position, continues to provide high-quality, localized, and regionalized content to audiences across 15 markets in Southeast Asia, the Middle East, and South Africa. During the year, Viu added 1.3 million net paying subscribers, bringing the total number of paying subscribers to a substantial 16.8 million.
Hong Kong Technology Exploration (01137.HK): Total GMV of orders in 2025 was 8.43 billion HKD, a slight decrease of 1.7% year-over-year.
Sunac Development (01030.HK): Contracted sales in January amounted to approximately 714 million RMB, a year-over-year decrease of 29.79%.
Yuzhou Group (01628.HK): Contracted sales in January were 530 million RMB, a year-over-year increase of 5.79%.
CITIC Securities (06030.HK): Its subsidiary, China AMC, achieved operating revenue of 9.626 billion yuan and net profit of 2.396 billion yuan in 2025.
Television Broadcasts (00511.HK): Announced a positive profit alert, expecting shareholders' attributable profit to exceed HKD 50 million in 2025, reversing losses from the previous year.
Dongyue Group (00189.HK): Announced a positive profit alert, expecting the attributable profit for company owners to increase by over 100% year-on-year in 2025.
Yue Yuen Industrial (00551.HK): The company's consolidated operating revenue in January was approximately USD 705 million, representing a year-on-year decrease of 12.5%.
Pou Sheng International (03813.HK): The company's consolidated operating revenue in January was 1.748 billion yuan, reflecting a year-on-year decline of 32.5%.
Minth Group (00425.HK): Plans to establish a joint venture with Aisin and Toyota to produce aluminum body frame components, aiming to strengthen the supply system for automotive aluminum body frames in the North American market.
Shijiazhuang No. 4 Pharmaceutical Group (02005.HK): On February 10, 2026, a total of 45 products were proposed to be awarded in the continuation procurement of China's First to Eighth Batches of National Centralized Drug Procurement (National Procurement), covering therapeutic areas such as anti-infection, cardiovascular system, respiratory system, digestive system, and nervous system, which is expected to have a positive impact on the group’s business.
Jinxun Resources (03636.HK): Plans to increase capital investment in overseas subsidiaries by a total of USD 44 million.
Guangdong-Hong Kong Investment Holdings (00124.HK): Granted a non-committed revolving loan facility of HKD 500 million.
Viva Biotech-B (09887.HK): Viva Pharma administered the first patient dose in the Phase IB/II trial for recurrent or metastatic triple-negative breast cancer.
China Nuclear Energy Technology (00611.HK): Plans to invest approximately 80.38264 million yuan to acquire all equity interests in Ningxia Tianping Boguang New Energy Co., Ltd.
Yuexiu Transportation Infrastructure (01052.HK): Entered into a proposed engineering agreement regarding the electromechanical engineering project for the reconstruction and expansion of Guangzhou North Second Ring Expressway.
Shoucheng Holdings (00697.HK): The fund under its management invested in Qimiao Labi, focusing on expanding the product portfolio around core intellectual property (IP).
Guoyin Financial Leasing (01606.HK): Entered into a financial lease arrangement involving wind power station equipment and ancillary facilities assets, with an investment of 1.02 billion yuan.
2) Financing and Share Repurchase Updates
Ascletis Pharma-B (01672.HK): Completed the placement of a total of 69.256 million shares at a placement price of 12.18 Hong Kong dollars per share, raising approximately 835 million Hong Kong dollars net proceeds, with about 90% intended for preparation, groundwork, and initiation of the global Phase III clinical trial of the small molecule oral GLP-1 receptor agonist ASC30 for the treatment of obesity.
Huatai Securities (06886.HK): Successfully issued zero-coupon convertible bonds maturing in 2027 with a principal amount of 10 billion Hong Kong dollars.
Geely Auto (00175.HK): Spent 29.899 million Hong Kong dollars to repurchase 1.804 million shares at repurchase prices ranging from 16.46 Hong Kong dollars to 16.78 Hong Kong dollars per share.
Bairong Inc.-W (06608.HK): Spent approximately 11.836 million Hong Kong dollars to repurchase 1.04 million shares at repurchase prices ranging from 11.31 Hong Kong dollars to 11.46 Hong Kong dollars per share.
